Is Pfizer a yield trap? No way.

Pfizer's vaccine business cooled off, and it is on its back foot in the GLP-1 race, but don't count the drug giant out.

How many profitable, large-cap healthcare companies pay a dividend yield of over 5%? Only one. Pfizer (NYSE: PFE) checks off all the boxes. It's profitable, raking in earnings of over $9.4 billion in ...

Pfizer yields 6.4% and has 46 consecutive years of dividend payments. On the surface, this looks like exactly the kind of ...

With an annual dividend yield of 6.37%, Pfizer Inc. (NYSE:PFE) is included among the 10 Best Fortune 500 Dividend Stocks to ...

Pfizer is dealing with headwinds right now, but they aren't unusual headwinds in the pharmaceutical sector. The company is taking aggressive actions to get back on track and recently stated it plans ...

Pfizer offers a 6.3% yield, but its high dividend reflects weak growth prospects and looming patent cliffs. PFE’s dividend is currently covered by cash flow, but payout ratios are stretched, and ...

Pfizer Inc. (NYSE:PFE) is included among the 15 Large Cap Stocks with Highest Dividends. Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical ...

Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%.

Pfizer (NYSE:PFE) reported Phase 2b results for its GLP-1 anti-obesity candidate, PF-08653944, showing potential for a once monthly injection. The company plans more than 20 anti-obesity trials, ...

Pfizer's dividend payout ratio is high, but the company is generated enough free cash flow to cover its dividend. Management remains committed to the dividend program despite Pfizer facing a patent ...